|1.||Lahlou, Saad: 9 articles (10/2005 - 08/2002)|
|2.||Leal-Cardoso, José Henrique: 8 articles (04/2005 - 08/2002)|
|3.||Magalhães, Pedro Jorge Caldas: 6 articles (10/2005 - 08/2002)|
|4.||Duarte, Gloria Pinto: 5 articles (04/2005 - 12/2002)|
|5.||Interaminense, Leylliane Fátima Leal: 4 articles (10/2005 - 06/2003)|
|6.||Berg, Torill: 3 articles (01/2015 - 09/2005)|
|7.||Nezhinskaia, G I: 3 articles (11/2008 - 04/2007)|
|8.||Sapronov, N S: 3 articles (11/2008 - 04/2007)|
|9.||Maslov, L N: 3 articles (04/2006 - 05/2001)|
|10.||Figueiredo, André Fernandes: 3 articles (10/2005 - 12/2002)|
|1.||Ganglion Cysts (Ganglion)
01/01/1994 - "Hexamethonium (0.5 mM) applied to the intestine, and not to the coeliac ganglion, reduced the frequency of the spontaneous synaptic potentials seen in coeliac ganglion cells, but did not abolish the response to distension of the colon (n = 8). "
05/04/1990 - "Administration of the nicotinic ganglion blocking agent hexamethonium (10 mg/kg i.v.) eliminated this response demonstrating that the release is mediated via an autonomic ganglion. "
09/01/1987 - "All studies were done during ganglion blockade with hexamethonium. "
12/01/2015 - "The increase in both glands was significantly inhibited by intravenous administration of the autonomic cholinergic ganglion blocker hexamethonium. "
06/01/2013 - "Interestingly, neuroprotection induced by remote postconditioning was partially prevented when ganglion transmission was pharmacologically interrupted by hexamethonium, thus showing that neural factors are involved in this phenomenon. "
09/01/2000 - "Ganglionic blockade with hexamethonium (300 microM) eliminated the tachycardia and pressor response but did not alter the tachypnea to forelimb stimulation (n = 3). "
02/01/2006 - "In the presence of hexamethonium (10 mg/kg), a ganglionic blocker, the tachycardia was completely prevented even though MAP was further reduced. "
04/08/1983 - "Hexamethonium (5-10 mg/kg) prevented pressor response and tachycardia in most cats but only partly protected against ECG changes and NM contractions. "
01/16/1981 - "It was possible to partly abolish the tachycardia by hexamethonium. "
05/01/2010 - "Both the transient bradycardia and following tachycardia responses are blocked with administration of the ganglionic blocker hexamethonium, demonstrating that these responses are mediated centrally. "
02/01/2012 - "MSNS-induced bradycardia was maintained with SCS but was mitigated by hexamethonium. "
10/01/2008 - "Bradycardia responses induced by mediastinal nerve stimulation were blunted by hexamethonium, but not by alpha(1,2)-adrenergic blockade. "
04/01/2008 - "Subsequent intravenous administration of hexamethonium bromide blocked both the remaining bradycardia and depressor responses. "
06/01/2006 - "This pressor response was accompanied by bradycardia in rabbits with either intact autonomic activity or hexamethonium-induced ganglionic blockade. "
07/15/2002 - "Deficiency of alpha5 subunits strikingly increased the sensitivity to a low concentration of hexamethonium, leading to a nearly complete blockade of bradycardia in response to vagal stimulation. "
|4.||Hypertension (High Blood Pressure)
10/08/1960 - "Hexamethonium trial as a diagnostic test of the principal forms of arterial hypertension"
10/10/1954 - "[Clinical study of hexamethonium in arterial hypertension]."
02/01/2012 - "Compared with LS rats, HR in HS rats was higher during the 2nd wk of ANG II, and its response to hexamethonium was greater on days 7, 10, and 13 of ANG II. These results suggest that ANG II-salt hypertension is associated with delayed changes in autonomic control of splanchnic resistance arteries and the heart."
10/01/2001 - "All NOS inhibitors and hexamethonium prevented the hypertension-induced increase in NO mediator cGMP in the choroid. "
12/01/1989 - "In the recovery period, the control dogs and the hexamethonium-treated dogs showed gradual increases in total peripheral resistance and in vasoconstricted hypertension 3 hours after stopping the infusion. "
|5.||Asthma (Bronchial Asthma)
02/01/2002 - "The hexamethonium asthma study and the death of a normal volunteer in research."
07/01/1985 - "Hexamethonium caused bronchoconstriction in all four subjects with asthma, which was reversed by atropine. "
01/01/2014 - "For example, ARIANA can capture the connection between the drug hexamethonium and pulmonary inflammation and fibrosis that caused the tragic death of a healthy volunteer in a 2001 John Hopkins asthma study, even though the abstract of the study was not part of the semantic model. "
07/01/1985 - "The degree of protection against inhaled histamine achieved by inhalation of the ganglion blocker hexamethonium bromide plus placebo, hexamethonium plus atropine sulphate, and placebo plus placebo was examined in six atopic subjects, four of whom had current asthma. "
|2.||Acetylcholine (Acetylcholine Chloride)
|5.||Hexamethonium (Hexamethonium Bromide)
|8.||Nicotinic Receptors (Nicotinic Acetylcholine Receptor)
|9.||Histamine (Histamine Dihydrochloride)
|3.||Vagus Nerve Stimulation